Loxo Oncology Lands $33,000,000 Series A Funding Round

  • Feed Type
  • Date
    10/4/2013
  • Company Name
    Loxo Oncology
  • Mailing Address
    Undisclosed New York, NY 10467
  • Company Description
    Loxo Oncology was incorporated in Delaware in May 2013 and was founded by Josh Bilenker, M.D., a partner at Aisling Capital. Loxo Oncology is committed to bringing targeted cancer therapies rapidly into the clinic that have an opportunity for outsized clinical effects in genetically defined patient populations.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $33,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    This funding allows us to advance our pipeline on multiple fronts.
  • M&A Terms
  • Venture Investor
    Aisling Capital
  • Venture Investor
    OrbiMed Advisors

By posting a comment, you agree to our terms and conditions.